Alyve Health: Financial Breakdown
Decoding financial health metrics of Alyve Health
Total Revenue₹8.2 Cr451%Prev. FY
Total Expenses₹16.5 Cr209%Prev. FY
Profit After Tax₹-4.6 Cr-21%Prev. FY
Total Assets₹11.0 Cr200%Prev. FY
Net Profit Margin-0.6%78%Prev. FY
FAQs on Financials of Alyve Health
No. In FY25, Alyve Health reported a net loss of ₹15.3 Cr, so it was not profitable.
Alyve Health's revenue grew 242.1% year-on-year, from ₹8.2 Cr in FY24 to ₹28.1 Cr in FY25.
Alyve Health's estimated EBITDA for FY25 was ₹-19.1 Cr, derived from its profit before tax, finance costs, and depreciation & amortisation.
In FY25, Alyve Health posted revenue of ₹28.1 Cr (up 242.1% YoY) and a net loss of ₹15.3 Cr. Explore the full financials of Alyve Health here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links